Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.
Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.
复制标题
DOI:
10.4161/onci.18852
复制
发表时间:
2012-05-01
期刊:
影响因子:
7.2
通讯作者:
Tartour E
中科院分区:
文献类型:
--
作者:
Pere H;Tanchot C;Bayry J;Terme M;Taieb J;Badoual C;Adotevi O;Merillon N;Marcheteau E;Quillien VR;Banissi C;Carpentier A;Sandoval F;Nizard M;Quintin-Colonna F;Kroemer G;Fridman WH;Zitvogel L;Oudard SP;Tartour E
CD4+CD25+Foxp3+ regulatory T cells (Treg) have emerged as a dominant T cell population inhibiting anti-tumor effector T cells. Initial strategies used for Treg-depletion (cyclophosphamide, anti-CD25 mAb…) also targeted activated T cells, as they share many phenotypic markers. Current, ameliorated approaches to inhibit Treg aim to either block their function or their migration to lymph nodes and the tumor microenvironment. Various drugs originally developed for other therapeutic indications (anti-angiogenic molecules, tyrosine kinase inhibitors,etc) have recently been discovered to inhibit Treg. These approaches are expected to be rapidly translated to clinical applications for therapeutic use in combination with immunomodulators.
登录
查看更多内容
DOI:
10.1084/jem.20042167
发表时间:
2005-05-16
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Ercolini AM;Ladle BH;Manning EA;Pfannenstiel LW;Armstrong TD;Machiels JP;Bieler JG;Emens LA;Reilly RT;Jaffee EM
通讯作者:
Jaffee EM
影响因子:
11.5
作者:
Badoual, C;Hans, S;Tartour, E
通讯作者:
Tartour, E
影响因子:
3.9
作者:
Bercovici, Nadege;Haicheur, Nacilla;Tartour, Eric
通讯作者:
Tartour, Eric
影响因子:
32.4
作者:
Boissonnas, Alexandre;Scholer-Dahirel, Alix;Amigorena, Sebastian
通讯作者:
Amigorena, Sebastian
影响因子:
5.8
作者:
Banissi, Claire;Ghiringhelli, Francois;Carpentier, Antoine F.
通讯作者:
Carpentier, Antoine F.